Michael Gelband’s Amgen AMGN Stock Holding History

Michael Gelband’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-29,231	Closed	-$8.25M	–	1505
2025 Q3	$8.25M	Buy	+29,231	New	+$8.48M	0.08%	244
2024 Q4	–	Sell	-2,786	Closed	-$898K	–	1481
2024 Q3	$898K	Buy	+2,786	New	+$911K	0.01%	1001
2023 Q3	–	Sell	-25,788	Closed	-$5.72M	–	1666
2023 Q2	$5.72M	Buy	+25,788	New	+$5.98M	0.05%	405
2023 Q1	–	Sell	-12,095	Closed	-$3.18M	–	1721
2022 Q4	$3.18M	Buy	+12,095	New	+$3.24M	0.05%	483
2022 Q3	–	Sell	-56,012	Closed	-$13.6M	–	1850
2022 Q2	$13.6M	Buy	56,012 +41,865	+296%	+$10.3M	0.17%	132
2022 Q1	$3.42M	Buy	+14,147	New	+$3.25M	0.04%	538
2021 Q4	–	Sell	-18,338	Closed	-$3.9M	–	2132
2021 Q3	$3.9M	Buy	18,338 +13,085	+249%	+$3.01M	0.05%	484
2021 Q2	$1.28M	Buy	+5,253	New	+$1.29M	0.01%	877
2020 Q4	–	Sell	-12,036	Closed	-$3.06M	–	1926
2020 Q3	$3.06M	Buy	+12,036	New	+$2.98M	0.06%	276
2020 Q2	–	Sell	-1,323	Closed	-$268K	–	1744
2020 Q1	$268K	Buy	+1,323	New	+$289K	0.01%	689
2019 Q4	–	Sell	-38,692	Closed	-$7.49M	–	1505
2019 Q3	$7.49M	Buy	+38,692	New	+$7.43M	0.26%	78

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Michael Gelband's AMGN Position: Q4 2025 in Review

Michael Gelband sold out of Amgen (AMGN) in Q4 2025, closing a stake of 29,231 shares — an estimated $8.25M sold.

Michael Gelband first reported a position in AMGN in Q3 2019 and held it in 11 quarters. The position peaked at $13.6M in Q2 2022. 3,091 funds tracked by Wall St. Rank hold AMGN as of Q4 2025.

Michael Gelband reported no remaining Amgen position as of Q4 2025 after selling out during the quarter.
Michael Gelband sold 29,231 Amgen shares in Q4 2025, an estimated $8.25M.
Michael Gelband first reported a position in Amgen in Q3 2019 and held it in 11 quarters.
Michael Gelband's Amgen position peaked at $13.6M in Q2 2022.
3,091 funds tracked by Wall St. Rank held Amgen as of Q4 2025.

Based on ExodusPoint Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.